Cargando…
MRI Characterizes the Progressive Course of AD and Predicts Conversion to Alzheimer’s Dementia 24 Months Before Probable Diagnosis
There is no disease-modifying treatment currently available for AD, one of the more impacting neurodegenerative diseases affecting more than 47.5 million people worldwide. The definition of new approaches for the design of proper clinical trials is highly demanded in order to achieve non-confounding...
Autores principales: | Salvatore, Christian, Cerasa, Antonio, Castiglioni, Isabella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5977985/ https://www.ncbi.nlm.nih.gov/pubmed/29881340 http://dx.doi.org/10.3389/fnagi.2018.00135 |
Ejemplares similares
-
Baseline MRI Predictors of Conversion from MCI to Probable AD in the ADNI Cohort
por: Risacher, Shannon L, et al.
Publicado: (2009) -
Magnetic resonance imaging biomarkers for the early diagnosis of Alzheimer's disease: a machine learning approach
por: Salvatore, Christian, et al.
Publicado: (2015) -
Serum 24‐hydroxycholesterol in probable Alzheimer's dementia: Reexploring the significance of a tentative Alzheimer's disease biomarker
por: Roy, Debashree, et al.
Publicado: (2019) -
AD Course Map charts Alzheimer’s disease progression
por: Koval, Igor, et al.
Publicado: (2021) -
Disease progression modelling from preclinical Alzheimer’s disease (AD) to AD dementia
por: Cho, Soo Hyun, et al.
Publicado: (2021)